Talphera TLPH
NASDAQ TLPH
$1.23 +0.01 (+0.82%)
As of: Sep 10, 2026 · 3:47 PM EDT

Talphera (TLPH) Other financing activities (2011 - 2026)

Talphera (TLPH) posted Other financing activities of -$245000.0 for Q2 2026, down 106.07% on a QoQ basis from $4.0 million in Q1 2026, and down 105.63% year-over-year from $4.4 million in Q2 2025.

Analysis

Talphera (TLPH) Other financing activities (2011 - 2026) Analysis & Trends

Talphera has reported Other financing activities for 11 years, with the latest figure at -$245000.0 in Q2 2026.

  • On a quarterly basis, Other financing activities fell 105.63% year-over-year to -$245000.0 in Q2 2026; TTM through Jun 2026 was $22.2 million, a 1574.52% increase from a year earlier, with the FY2025 full-year figure at $22.7 million, up 84059.26% from the prior year.
  • Other financing activities was -$245000.0 for Q2 2026 at Talphera, down from $4.0 million in the prior quarter.
  • The five-year high for Other financing activities was $17.0 million in Q3 2025, with the low at -$5.9 million in Q4 2024.
  • Average Other financing activities over 5 years is $2.2 million, with a median of $44500.0 recorded in 2022.
  • The largest YoY upside for Other financing activities was 18880.65% in 2024 against a maximum downside of 26522.73% in 2024.
  • Over 5 years, Other financing activities stood at $16000.0 in 2022, then plunged by 237.5% to -$22000.0 in 2023, then sank by 26522.73% to -$5.9 million in 2024, then surged by 123.73% to $1.4 million in 2025, then sank by 117.63% to -$245000.0 in 2026.
  • The last three Other financing activities figures came in at -$245000.0 (Q2 2026), $4.0 million (Q1 2026), and $1.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.58 Bn 192.59 Bn 7.24 Bn
2 Gilead Sciences 180.17 Bn 176.99 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.59 Bn 122.74 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.61 Bn 73.61 Bn 3.93 Bn
5 Argenx Se 60.24 Bn 55.05 Bn 1.37 Bn
6 Moderna 54.29 Bn 49.15 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 32.96 Bn 29.65 Bn 992.69 Mn
8 Biogen 31.94 Bn 30.66 Bn 1.96 Bn
9 Roivant Sciences 29.38 Bn 29.38 Bn 1.16 Mn
10 Talphera 92.90 Mn 92.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -245,000.00
Mar 31, 2026 4.04 Mn
Dec 31, 2025 1.39 Mn
Sep 30, 2025 16.98 Mn
Jun 30, 2025 4.35 Mn
Dec 31, 2024 -5.86 Mn
Mar 31, 2024 5.88 Mn
Dec 31, 2023 -22,000.00
Sep 30, 2023 14,000.00
Mar 31, 2023 31,000.00
Sep 30, 2022 16,000.00
Mar 31, 2022 58,000.00
Sep 30, 2021 122,000.00
Jun 30, 2021 2,000.00
Mar 31, 2021 194,000.00
Sep 30, 2020 154,000.00
Jun 30, 2020 132,000.00
Mar 31, 2020 86,000.00
Dec 31, 2019 1,000.00
Sep 30, 2019 317,000.00